» Articles » PMID: 35891354

HYGIEIA: HYpothesizing the Genesis of Infectious Diseases and Epidemics Through an Integrated Systems Biology Approach

Abstract

More than two years on, the COVID-19 pandemic continues to wreak havoc around the world and has battle-tested the pandemic-situation responses of all major global governments. Two key areas of investigation that are still unclear are: the molecular mechanisms that lead to heterogenic patient outcomes, and the causes of Post COVID condition (AKA Long-COVID). In this paper, we introduce the HYGIEIA project, designed to respond to the enormous challenges of the COVID-19 pandemic through a multi-omic approach supported by network medicine. It is hoped that in addition to investigating COVID-19, the logistics deployed within this project will be applicable to other infectious agents, pandemic-type situations, and also other complex, non-infectious diseases. Here, we first look at previous research into COVID-19 in the context of the proteome, metabolome, transcriptome, microbiome, host genome, and viral genome. We then discuss a proposed methodology for a large-scale multi-omic longitudinal study to investigate the aforementioned biological strata through high-throughput sequencing (HTS) and mass-spectrometry (MS) technologies. Lastly, we discuss how a network medicine approach can be used to analyze the data and make meaningful discoveries, with the final aim being the translation of these discoveries into the clinics to improve patient care.

Citing Articles

Deep Plasma Proteomics with Data-Independent Acquisition: Clinical Study Protocol Optimization with a COVID-19 Cohort.

Ward B, Pyr Dit Ruys S, Balligand J, Belkhir L, Cani P, Collet J J Proteome Res. 2024; 23(9):3806-3822.

PMID: 39159935 PMC: 11385417. DOI: 10.1021/acs.jproteome.4c00104.


NMR-Based Chromatography Readouts: Indispensable Tools to "Translate" Analytical Features into Molecular Structures.

Seger C, Sturm S Cells. 2022; 11(21).

PMID: 36359922 PMC: 9658744. DOI: 10.3390/cells11213526.

References
1.
Manzoni C, Kia D, Vandrovcova J, Hardy J, Wood N, Lewis P . Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences. Brief Bioinform. 2016; 19(2):286-302. PMC: 6018996. DOI: 10.1093/bib/bbw114. View

2.
Funk T, Pharris A, Spiteri G, Bundle N, Melidou A, Carr M . Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021. Euro Surveill. 2021; 26(16). PMC: 8063589. DOI: 10.2807/1560-7917.ES.2021.26.16.2100348. View

3.
Park J, Kim H, Kim S, Kim Y, Lee J, Dan K . In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients. Sci Rep. 2020; 10(1):22418. PMC: 7772338. DOI: 10.1038/s41598-020-80120-8. View

4.
Reynaert N, Gopal P, Rutten E, Wouters E, Schalkwijk C . Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease. Int J Biochem Cell Biol. 2016; 81(Pt B):403-418. DOI: 10.1016/j.biocel.2016.06.016. View

5.
Sheikh A, McMenamin J, Taylor B, Robertson C . SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. Lancet. 2021; 397(10293):2461-2462. PMC: 8201647. DOI: 10.1016/S0140-6736(21)01358-1. View